Dr Ceri Cashell is calling on the government to put a testosterone treatment for women on the PBS.
Share and Follow

A key treatment which could help around one million middle-aged Australian women remains unaffordable to many because it is unsubsidised by the government, experts warn.

More than 10,000 people have signed a Change.org petition calling for testosterone treatment AndroFeme to be added to the Pharmaceutical Benefits Scheme (PBS).

The petition was started by Dr Ceri Cashell, a Sydney GP and the co-founder of Healthy Hormones, a national platform which aims to provide education and advocacy for menopause healthcare.

Dr Ceri Cashell is calling on the government to put a testosterone treatment for women on the PBS.
Dr Ceri Cashell, a Sydney GP, is calling on the government to put a testosterone treatment for women on the PBS. (Supplied)

Cashell said the federal government’s decision to add body-identical estrogen and progesterone treatments to the PBS, which came into effect in March, had been a game-changer in making hormone replacement therapy more affordable for women going through menopause.

However, testosterone remained the one vital hormone still locked behind private scripts and high out-of-pocket costs, she added.

“Many midlife women need all three hormones — estrogen, progesterone and testosterone — to function and feel like themselves again,” Cashell said.

“AndroFeme (testosterone) can be the missing piece for many women. It’s safe, effective, and approved.

“But for most, it’s simply unaffordable.”

AndroFeme, the only testosterone product for women approved by the Therapeutic Goods Administration (TGA), is designed to help women regain lost libido as a result of hormone changes during menopause.

Australia became the first country to license the medication in 2020, and was followed by the UK and South Africa.

Despite nine testosterone products being available on the PBS for men, AndroFeme was yet to be added to the subsidy scheme for women, Cashell said.

AndroFeme costs around $100 to $180 for a three-month supply, depending on the dosage needed.

Even in the relatively affluent Northern Beaches area where Cashell practices, women were choosing not to add testosterone hormones to their treatment because of the cost, she said.

“Frequently, patients say it works, but they just can’t afford it,” Cashell said.

“Women are really bad at putting themselves first, and they put themselves low on the household budget. 

“As soon as there’s a cost barrier, then they often won’t pursue that treatment.” 

Cashell said the only other option for women seeking testosterone treatment was to use off-label testosterone medication designed for men, which was cheaper, despite not being available for women through the PBS.

However, it was harder to get the dosage right for women using off-label male testosterone treatments and therefore came with higher risks, Cashell said.

While around 15,000 Australian women were currently taking testosterone, there were exponentially more who could benefit from it, Cashell said.

An Australian study published in the National Library of Medicine in 2020 found a third of women aged between 40 and 65 were affected by low sexual desire with associated distress.

Even applying those figures to women only aged between 50-65 would mean around one million Australian women would meet the criteria for treatment, Cashell said.

AndroFeme is only approved by the TGA for the treatment of low libido, however, emerging data was beginning to show the treatment could have other health benefits, including improved wellbeing and cognitive function, she added.

Author and podcaster Cathrine Mahoney said she started taking testosterone, along with progesterone and estrogen, as part of her “perimenopause trifecta” about 18 months ago.

Podcaster Cathrine Mahoney believes testosterone treatment should be  made accessible for Australian women.
Podcaster Cathrine Mahoney believes testosterone treatment should be made accessible for Australian women. (Supplied)

“For me, the reason I wanted to put it in the mix was twofold,” she said.

“My libido had left the building, I think I was 48 at the time, and that’s way too soon for that to happen. And I just didn’t have my full ‘pep’ back, that’s the only way I can describe it.”

A long-time fan of regular exercise, Mahoney said when perimenopause hit she no longer felt like she had the same level of energy for workouts.

Mahoney said the testosterone treatment had seemed to help with both symptoms.

“My libido is firing, which is great news. And, also, I just feel I’ve got my get-up-and-go back,” she said.

Mahoney said she had only heard about the potential benefits of testosterone during menopause after listening to a podcast, after which she spoke to her GP.

“It’s just something I think should be affordable and accessible, and women should know about it. Then it’s up to them and their GP to work out if that’s something they should have in the mix or not,” she said.

Last year, a parliamentary inquiry into perimenopause and menopause found women were being severely impacted by the cost of accessing newer hormone treatments.

The finding led to the federal government announcing the inclusion of three menopausal hormone therapies — Estrogel Pro, Estrogel and Prometrium – on the PBS as part of a half-a-billion-dollar women’s health package.

A spokesperson for the Department of Health, Disability and Ageing said adding any medicine to the PBS required a submission to the Pharmaceutical Benefits Advisory Committee, which then needed to be given the tick of approval by the committee.

Share and Follow
You May Also Like
I was broke and homeless but now I make six figures… here is how I turned my life around

From Homeless to Six Figures: My Journey to Success and Financial Freedom

A man who was broke and homeless but now rakes in hundreds…
Australian supermodel Miranda Kerr shares moving tribute to legendary jeweller Sir Michael Hill after his death at age 86: 'Deeply saddened'

Australian supermodel Miranda Kerr deeply mourns the passing of legendary jeweller Sir Michael Hill at 86

Miranda Kerr has shared her sorrow after the death of Sir Michael Hill,…
Wesley LePatner, an executive at Blackstone Inc., who was shot and killed by a gunman on July 29 at the company's headquarters in New York.

‘Loved Ones Commemorate ‘Hero’ as New York Shooting Victims Are Remembered’

A New York City police officer and an executive at an investment…
Then-senior constable Kristian James Samuel White, 35, fired his Taser at 95-year-old Clare Nowland.

Court Maintains ‘Lenient’ Sentence for Officer in Taser Incident Involving Great-Grandmother

A decision not to imprison the former police officer who fatally tasered…
A row of soft drink cans.

How Drinking Soft Drinks Can Raise Your Diabetes Risk by Over 30%

Drinking artificially-sweetened soft drinks increases the risk of developing type 2 diabetes…
Trump slaps blanket 50 per cent tariff on crucial resource

Trump Imposes 50% Tariff on Essential Resource

US President Donald Trump said the White House was “very busy” crafting…
Government won't be 'intimidated' by social media giants after landmark under-16 ban

Government Stands Firm Against Social Media Giants Following Landmark Under-16 Ban

The federal government has warned social media giants it will not be…
Charlie Verco in Hawaii tsunami warning

Australian Trapped in Hawaii Reports Locals ‘Panic Buying’ After Tsunami Alert

An Australian paddleboarder in Hawaii said he and a group of mates…